Jul 05 2012
12:00 p.m. | Christiana Care's Helen F. Graham Cancer Center | 4701 Ogletown-Stanton Road | Newark, Del.
WILMINGTON – On Thursday, July 5, 2012, U.S. Senator Tom Carper (D-Del.) will join local stakeholders to celebrate the passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) at the Helen F. Graham Cancer Center at Christiana Care Health System in Newark, Del. FDASIA reauthorizes the Prescription Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA).
"This bill helps ensure that Americans get access to the life-saving medications and medical devices that are developed in this country – including Delaware – as soon and as safely as possible," said Sen. Tom Carper. "It improves the Food and Drug Administration's ability to review and regulate drugs and medical devices for adults and children. This legislation also helps to protect patients' access to critical medicines by creating new programs to incentivize the development of new antibiotics and reduce drug shortages. Patients, health care providers, and the pharmaceutical and medical device industries will all benefit from a more responsive and effective Food and Drug Administration– a win-win for Delaware consumers and businesses."
Event to highlight Food and Drug Administration Safety and Innovation Act
Thursday, July 5, 2012, 12 p.m. – 1 p.m.
U.S. Senator Tom Carper
Nicholas Petrelli, M.D., Bank of America-endowed Medical Director of the Christiana Care Health System's Helen F. Graham Cancer Center
Paul Friedman, M.D., President and Chief Executive Officer, Incyte
Tyrone Jones, Director of Delaware External Affairs, AstraZeneca
Theresa Haenn, Executive Director of the Eastern PA/Delaware Chapter, Juvenile Diabetes Research Foundation
Anders "Andy" Kolb, Director of the Center for Cancer and Blood Disorders at Nemours/Alfred I. duPont Hospital for Children
Christiana Care's Helen F. Graham Cancer Center, 4701 Ogletown-Stanton Road, Newark, DE 19713